The further study of such markers related to ADGRL4/ELTD1 function will also provide valuable information for monitoring the efficacy of future therapies aiming to inhibit the expression and/or function of ADGRL4/ELTD1 in the tumour microenvironment. Here, ADGRL4 is linked to neoplasm.